avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Srf | mm10_v2_chr17_-_46556158_46556188 | 0.36 | 3.0e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142661305 Show fit | 11.89 |
ENSMUST00000105936.1
|
insulin-like growth factor 2 |
|
chr2_-_114052804 Show fit | 9.75 |
ENSMUST00000090269.6
|
actin, alpha, cardiac muscle 1 |
|
chr8_-_123894736 Show fit | 8.13 |
ENSMUST00000034453.4
|
actin, alpha 1, skeletal muscle |
|
chr7_-_142661858 Show fit | 6.08 |
ENSMUST00000145896.2
|
insulin-like growth factor 2 |
|
chr4_+_46039202 Show fit | 5.27 |
ENSMUST00000156200.1
|
tropomodulin 1 |
|
chrX_+_101449078 Show fit | 4.71 |
ENSMUST00000033674.5
|
integrin beta 1 binding protein 2 |
|
chr7_+_19411086 Show fit | 3.72 |
ENSMUST00000003643.1
|
creatine kinase, muscle |
|
chr11_-_94973447 Show fit | 3.63 |
ENSMUST00000100551.4
ENSMUST00000152042.1 |
sarcoglycan, alpha (dystrophin-associated glycoprotein) |
|
chr8_+_15057646 Show fit | 3.43 |
ENSMUST00000033842.3
|
myomesin 2 |
|
chr6_-_83536215 Show fit | 3.28 |
ENSMUST00000075161.5
|
actin, gamma 2, smooth muscle, enteric |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 23.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
2.2 | 18.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 7.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 3.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 3.7 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 3.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.3 | 3.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 3.2 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 2.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 2.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 23.6 | GO:0031674 | I band(GO:0031674) |
0.0 | 19.0 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 13.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.2 | 5.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 4.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.2 | 3.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 3.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.4 | 3.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 2.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.2 | GO:0016460 | myosin II complex(GO:0016460) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.0 | GO:0043539 | insulin-like growth factor receptor binding(GO:0005159) protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 11.8 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 7.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 5.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 4.3 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 4.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.6 | 3.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 2.6 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 2.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 2.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 17.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 8.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 7.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 3.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 1.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 18.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 10.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 5.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 3.7 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |